Cita APA

Oh, J., Barve, M., Senzer, N., Aaron, P., Manning, L., Wallraven, G., . . . Rocconi, R. P. (2020). Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance. Gynecol Oncol Rep.

Chicago Style Citation

Oh, Johnathan, et al. "Long-term Follow-up of Phase 2A Trial Results Involving Advanced Ovarian Cancer Patients Treated With Vigil® in Frontline Maintenance." Gynecol Oncol Rep 2020.

Cita MLA

Oh, Johnathan, et al. "Long-term Follow-up of Phase 2A Trial Results Involving Advanced Ovarian Cancer Patients Treated With Vigil® in Frontline Maintenance." Gynecol Oncol Rep 2020.